Additionally, Mcl-1 expression was inhibited by targeting of the mTOR pathway using the rapalouge RAD001/everolimus, promoting increased tumor cell killing in in vivo models of colon cancer [61]. This evidence concerns the gene MCL1 and neoplasm.